FDA holds firm on 60-day comment period for lab-developed test rule

The Food and Drug Administration said it is sticking with a standard 60-day timeframe for the public to provide feedback on its proposed rule to increase oversight of laboratory-developed tests (LDTs), despite receiving requests to extend the window.